The paper examines 5189 Indian publications on breast cancer research, as covered in Scopus database during 2005–2014, experiencing an annual average growth rate of 21.94% and citation impact of 3.38. The world breast cancer output (203,879 publications) came from several countries, of which the top 15 most productive countries (United States, U.K., China, Germany, Italy, Canada, France, Japan, etc.,) accounted for 89.89% share of the global output during 2005–2014. India’s global publication share was 2.55% and hold 12th rank in global output during 2005–2014. The Indian publications on breast cancer came from several organizations, of which the top 15 most productive contributed 27.89% share in the national breast cancer output during 2005–2014. India’s international collaborative publications share in breast cancer was 19.89% during 2005–2014, which increased from 19.25% to 20.11% from 2005–2009 to 2010–2014. Medicine accounted for the largest share (54.58%) of output in breast cancer, followed by biochemistry, genetics and molecular biology (38.08%), pharmacology, toxicology and pharmaceutics (23.11%), chemistry (11.29%), agricultural and biological sciences (3.87% share) and immunology and microbiology (2.04% share) during 2005–2014. Diagnosis, chemotherapy, screening, prognosis, surgery and radiotherapy together account for 72.58% publications share among treatments methods used in Indian breast cancer research during 2005–2014. Maharashtra, Delhi, Tamil Nadu and Karnataka together accounted for 53.52% of the India’s breast cancer output during 2005–2014.